The U.S. Centers for Disease Control and Prevention (CDC) is seeking information on sources with the manufacturing capability and surge capacity to produce chemical, biological, radiological, and nuclear (CBRN) threat agent countermeasures.
The overall goal of the effort is to inform stockpile acquisition strategies in support of public health preparedness and response needs.
The Request for Information specifically seeks to better understand the availability amoxicillin, doxycycline and ciprofloxacin.
Further details are available under Solicitation Number: 2015-RFI-16957. The response deadline is March 3, 2015.